Abstract
Background: Temporomandibular joint (TMJ) disorders are associated with severe pain and functional impairment. Although thread embedding acupuncture (TEA) is commonly used for the management of temporomandibular disorders (TMD) at clinical sites, evidence supporting its use remains insufficient. This study aimed to evaluate the efficacy, safety, and cost-effectiveness of TEA for the treatment of chronic TMJ disorders. Methods: This randomized, assessor-blinded, controlled clinical trial included 76 patients with chronic TMD. Participants will be randomly allocated to either the TEA or the conventional treatment group. The TEA group will receive treatment administered at 16 predetermined acupoints for six weeks. The usual care group will receive transcutaneous electrical nerve stimulation (TENS) and infrared therapy. Results: The primary outcome was average pain intensity measured using the Visual Analog Scale (VAS). The secondary outcomes will include maximum pain intensity (VAS), vertical TMJ opening, Graded Chronic Pain 2.0, Jaw Functional Limitation Scale-20, Patient Global Impression of Change, EuroQol 5-Dimension 5-level (EQ-5D-5L), adverse events, and medical costs for economic evaluation. Conclusion: This study provides evidence for the efficacy and safety of TEA for chronic TMJ disorders and explores its potential as a cost-effective treatment. Trial registration: This study was registered with the Clinical Research Information Service of the Republic of Korea (Registration Number: KCT0009946).
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
KCT0009946
Clinical Protocols
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study protocol was approved by the IRB of Kyung Hee University Oriental Medicine Hospital at Gangdong [IRB Number: KHNMCOH IRB 2024-08-002].
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos